Novartis Investigative Site

Meppel 7943 KA

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Chronic Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early